AAAAAA

   
Results: 1-25 | 26-50 | 51-64
Results: 1-25/64

Authors: KATABIRA ET SEWANKAMBO NK MUGERWA RD BELSEY EM MUBIRU FX OTHIENO C KATAAHA P KARAM M YOULE M PERRIENS JH LANGE JMA
Citation: Et. Katabira et al., LACK OF EFFICACY OF LOW-DOSE ORAL INTERFERON-ALPHA IN SYMPTOMATIC HIV-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, SEXUALLY TRANSMITTED INFECTIONS, 74(4), 1998, pp. 265-270

Authors: LANGE JMA RICHMAN DD
Citation: Jma. Lange et Dd. Richman, THE LIMITATIONS OF SIMPLICITY, Antiviral therapy, 3(1), 1998, pp. 4-6

Authors: VEENSTRA J LANGE JMA
Citation: J. Veenstra et Jma. Lange, CUTANEOUS ADVERSE REACTIONS AND CD4(-INFECTED PATIENTS RECEIVING TRIMETHOPRIM-SULFAMETHOXAZOLE - REPLY() CELL COUNTS IN HUMAN IMMUNODEFICIENCY VIRUS), Clinical infectious diseases, 26(2), 1998, pp. 531-532

Authors: VANDAMME L NIRUTHISARD S ATISOOK R BOER K DALLY L LAGA M LANGE JMA KARAM M PERRIENS JH
Citation: L. Vandamme et al., SAFETY EVALUATION OF NONOXYNOL-9 GEL IN WOMEN AT LOW-RISK OF HIV-INFECTION, AIDS, 12(4), 1998, pp. 433-437

Authors: HOETELMANS RMW VANHEESWIJK RPG PROFIJT M MULDER JW MEENHORST PL LANGE JMA REISS P BEIJNEN JH
Citation: Rmw. Hoetelmans et al., COMPARISON OF THE PLASMA PHARMACOKINETICS AND RENAL CLEARANCE OF DIDANOSINE DURING ONCE AND TWICE-DAILY DOSING IN HIV-1-INFECTED INDIVIDUALS, AIDS, 12(17), 1998, pp. 211-216

Authors: HAVLIR DV LANGE JMA
Citation: Dv. Havlir et Jma. Lange, NEW ANTIRETROVIRALS AND NEW COMBINATIONS (VOL 12, PG S165, 1998), AIDS, 12(15), 1998, pp. 18-18

Authors: ENTING RH HOETELMANS RMW LANGE JMA BURGER DM BEIJNEN JH PORTEGIES P
Citation: Rh. Enting et al., ANTIRETROVIRAL DRUGS AND THE CENTRAL-NERVOUS-SYSTEM, AIDS, 12(15), 1998, pp. 1941-1955

Authors: FOUDRAINE NA DEJONG JJ WEVERLING GJ VANBENTHEM BHB MAAS J KEET IPM JURRIAANS S ROOS MTL VANDERMEULEN K DEWOLF F LANGE JMA
Citation: Na. Foudraine et al., AN OPEN RANDOMIZED CONTROLLED TRIAL OF ZIDOVUDINE PLUS LAMIVUDINE VERSUS STAVUDINE PLUS LAMIVUDINE, AIDS, 12(12), 1998, pp. 1513-1519

Authors: HOETELMANS RMW REIJERS MHE WEVERLING GJ TENKATE RW WIT FWNM MULDER JW WEIGEL HM FRISSEN PHJ ROOS M JURRIAANS S SCHUITEMAKER H DEWOLF F BEIJNEN JH LANGE JMA
Citation: Rmw. Hoetelmans et al., THE EFFECT OF PLASMA DRUG CONCENTRATIONS ON HIV-1 CLEARANCE RATE DURING QUADRUPLE DRUG-THERAPY, AIDS, 12(11), 1998, pp. 111-115

Authors: WEVERLING GJ LANGE JMA JURRIAANS S PRINS JM LUKASHOV VV NOTERMANS DW ROOS M SCHUITEMAKER H HOETELMANS RMW DANNER SA GOUDSMIT J DEWOLF F
Citation: Gj. Weverling et al., ALTERNATIVE MULTIDRUG REGIMEN PROVIDES IMPROVED SUPPRESSION OF HIV-1 REPLICATION OVER TRIPLE THERAPY, AIDS, 12(11), 1998, pp. 117-122

Authors: FOUDRAINE NA WEVERLING GJ VANGOOL T ROOS MTL DEWOLF F KOOPMANS PP VANDENBROEK PJ MEENHORST PL VANLEEUWEN R LANGE JMA REISS P
Citation: Na. Foudraine et al., IMPROVEMENT OF CHRONIC DIARRHEA IN PATIENTS WITH ADVANCED HIV-1 INFECTION DURING POTENT ANTIRETROVIRAL THERAPY, AIDS, 12(1), 1998, pp. 35-41

Authors: DEJONG MD BOUCHER CAB DANNER SA GAZZARD B GRIFFITHS PD KATLAMA C LANGE JMA RICHMAN DD VELLA S
Citation: Md. Dejong et al., SUMMARY OF THE INTERNATIONAL CONSENSUS SYMPOSIUM ON MANAGEMENT OF HIV, CMV AND HEPATITIS-VIRUS INFECTIONS, Antiviral research, 37(1), 1998, pp. 1-16

Authors: REIJERS MHE WEVERLING GJ JURRIAANS S WIT FWNM WEIGEL HM TENKATE RW MULDER JW FRISSEN PHJ VANLEEUWEN R REISS P SCHUITEMAKER H DEWOLF F LANGE JMA
Citation: Mhe. Reijers et al., MAINTENANCE THERAPY AFTER QUADRUPLE INDUCTION THERAPY IN HIV-1-INFECTED INDIVIDUALS - AMSTERDAM DURATION OF ANTIRETROVIRAL MEDICATION (ADAM) STUDY, Lancet, 352(9123), 1998, pp. 185-190

Authors: FOUDRAINE NA HOETELMANS RMW LANGE JMA DEWOLF F VANBENTHEM BHB MASS JJ KEET IPM PORTEGIES P
Citation: Na. Foudraine et al., CEREBROSPINAL-FLUID HIV-1 RNA AND DRUG CONCENTRATIONS AFTER TREATMENTWITH LAMIVUDINE PLUS ZIDOVUDINE OR STAVUDINE, Lancet, 351(9115), 1998, pp. 1547-1551

Authors: MONTANER JSG REISS P COOPER D VELLA S HARRIS M CONWAY B WAINBERG MA SMITH D ROBINSON P HALL D MYERS M LANGE JMA
Citation: Jsg. Montaner et al., A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING COMBINATIONS OF NEVIRAPINE, DIDANOSINE, AND ZIDOVUDINE FOR HIV-INFECTED PATIENTS - THE INCAS TRIAL, JAMA, the journal of the American Medical Association, 279(12), 1998, pp. 930-937

Authors: PAKKER NG ROOS MTL VANLEEUWEN R DEJONG MD KOOT M REISS P LANGE JMA MIEDEMA F DANNER SA SCHELLEKENS PTA
Citation: Ng. Pakker et al., PATTERNS OF T-CELL REPOPULATION, VIRUS LOAD REDUCTION, AND RESTORATION OF T-CELL FUNCTION IN HIV-INFECTED PERSONS DURING THERAPY WITH DIFFERENT ANTIRETROVIRAL AGENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 16(5), 1997, pp. 318-326

Authors: VEENSTRA J VEUGELERS PJ KEET IPM VANDERVEN AJAM MIEDEMA F LANGE JMA COUTINHO RA
Citation: J. Veenstra et al., RAPID DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS WITH ADVERSE REACTIONS TO TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS, Clinical infectious diseases, 24(5), 1997, pp. 936-941

Authors: DEJONG MD DEBOER RJ DEWOLF F FOUDRAINE NA BOUCHER CAB GOUDSMIT J LANGE JMA
Citation: Md. Dejong et al., OVERSHOOT OF HIV-1 VIREMIA AFTER EARLY DISCONTINUATION OF ANTIRETROVIRAL TREATMENT, AIDS, 11(11), 1997, pp. 79-84

Authors: DEJONG MD BOUCHER CAB COOPER DA GALASSO GJ GAZZARD B LANGE JMA MONTANER JS RICHMAN DD THOMAS HC
Citation: Md. Dejong et al., SUMMARY OF THE 2ND INTERNATIONAL CONSENSUS SYMPOSIUM ON COMBINED ANTIVIRAL THERAPY AND IMPLICATIONS FOR FUTURE THERAPIES, Antiviral research, 35(2), 1997, pp. 65-82

Authors: LANGE JMA
Citation: Jma. Lange, ANTIRETROVIRAL DRUG TRIALS - RESPONSE, Science, 276(5318), 1997, pp. 1483-1484

Authors: LANGE JMA
Citation: Jma. Lange, CURRENT PROBLEMS AND THE FUTURE OF ANTIRETROVIRAL DRUG TRIALS, Science, 276(5312), 1997, pp. 548-550

Authors: FRISSEN PHJ DEWOLF F REISS P BAKKER PJM VEENHOF CHN DANNER SA GOUDSMIT J LANGE JMA
Citation: Phj. Frissen et al., HIGH-DOSE INTERFERON-ALPHA-2A EXERTS POTENT ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NOT ASSOCIATED WITH ANTITUMOR-ACTIVITY IN SUBJECTS WITH KAPOSIS-SARCOMA, The Journal of infectious diseases, 176(3), 1997, pp. 811-814

Authors: VANLEEUWEN R BONSEL GJ REISS P DANNER SA LANGE JMA
Citation: R. Vanleeuwen et al., ADDITIVE OR SEQUENTIAL NUCLEOSIDE ANALOG THERAPY COMPARED WITH CONTINUED ZIDOVUDINE MONOTHERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH ADVANCED DISEASE DOES NOT PROLONG SURVIVAL - AN OBSERVATIONAL STUDY, The Journal of infectious diseases, 175(6), 1997, pp. 1344-1351

Authors: DEJONG MD VELLA S CARR A BOUCHER CAB IMRIE A FRENCH M HOY J SORICE S PAULUZZI S CHIODO F WEVERLING GJ VANDERENDE ME FRISSEN PJ WEIGEL HM KAUFFMANN RH LANGE JMA YOON R MORONI M HOENDERDOS E LEITZ G COOPER DA HALL D REISS P
Citation: Md. Dejong et al., HIGH-DOSE NEVIRAPINE IN PREVIOUSLY UNTREATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT RESULT IN SUSTAINED SUPPRESSION OF VIRAL REPLICATION, The Journal of infectious diseases, 175(4), 1997, pp. 966-970

Authors: VANTWOUT AB RAN LJ DEJONG MD BAKKER M VANLEEUWEN R NOTERMANS DW LOELIGER AE DEWOLF F DANNER SA REISS P BOUCHER CAB LANGE JMA SCHUITEMAKER H
Citation: Ab. Vantwout et al., SELECTIVE-INHIBITION OF SYNCYTIUM-INDUCING AND NONSYNCYTIUM-INDUCING HIV-1 VARIANTS IN INDIVIDUALS RECEIVING DIDANOSINE OR ZIDOVUDINE, RESPECTIVELY, The Journal of clinical investigation, 100(9), 1997, pp. 2325-2332
Risultati: 1-25 | 26-50 | 51-64